Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
Filings by filing date
News
Biz Brief
Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 121 Derech Menachem Begin, 30th Floor TEL AVIV-YAFO 6701203 |
Tel: | N/A |
Website: | https://todosmedical.com |
IR: | See website |
Key People | ||
N/A |
Business Overview |
Todos Medical Ltd is a Israel-based clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer. The Companys Total Biochemical Infrared Analysis (TBIA) platform, represents a method for cancer screening of solid tumors using peripheral blood spectroscopy analysis. The process involves observing the immune system's response to tumor presence. TBIA analyzes the entire biochemical signatures spectrum including proteins, lipids, nucleic acids and carbohydrates of effected immune cells from peripheral blood, using infrared spectroscopy. |
Financial Overview |
For the nine months ended 30 September 2022, Todos Medical Ltd revenues decreased 19% to $6.3M. Net loss decreased 19% to $20M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Financing income (expenses), net decrease of 32% to $11.7M (expense), Share in losses of affiliated companies decrease from $1.5M (expense) to $0K. |
Employees: | 7 as of Dec 31, 2020 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $36.21M as of Sep 30, 2022 |
Annual revenue (TTM): | $10.75M as of Sep 30, 2022 |
EBITDA (TTM): | -$10.33M as of Sep 30, 2022 |
Net annual income (TTM): | -$38.77M as of Sep 30, 2022 |
Free cash flow (TTM): | -$5.74M as of Sep 30, 2022 |
Net Debt Last Fiscal Year: | $36.21M as of Sep 30, 2022 |
Shares outstanding: | 2,130,423,853 as of Mar 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |